2014
DOI: 10.4236/ojmp.2014.31008
|View full text |Cite
|
Sign up to set email alerts
|

A Comparison of Clinical Features of Depressed and Non-Depressed People Living with HIV/AIDS, in Nigeria, West Africa

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…A total of 116 clinical and demographic variables typically available in medical claims databases were utilized as predictors associated with depression symptom severity. Variables were identified from (1) a literature search and review of publications, including studies related to causation or association of MDD or depression symptom severity (Amos et al., 2017; APA, 2013; Briggs et al, 2018; Carter et al., 2012; Chin et al., 2016; Gaynes, 2009; Gross et al., 2015; Hinz et al., 2016; Iosifescu et al., 2003; Katzelnick et al., 2011; Mulvahill et al., 2017; Raval et al., 2010; Rossom et al., 2016; Shittu et al., 2014; Wada et al., 2015; Waxmonsky et al., 2012), and (2) discussions with clinicians with expertise in treating patients with TRD. The potential predictors included demographic characteristics, treatment‐specific variables (e.g., site of care, nonpharmacologic treatment, number of prior MDD treatments, specific medications taken for MDD treatment), psychiatric comorbidities, medical comorbidities, measures of healthcare resource utilization, and others (see Table S2 for a full list of variables).…”
Section: Methodsmentioning
confidence: 99%
“…A total of 116 clinical and demographic variables typically available in medical claims databases were utilized as predictors associated with depression symptom severity. Variables were identified from (1) a literature search and review of publications, including studies related to causation or association of MDD or depression symptom severity (Amos et al., 2017; APA, 2013; Briggs et al, 2018; Carter et al., 2012; Chin et al., 2016; Gaynes, 2009; Gross et al., 2015; Hinz et al., 2016; Iosifescu et al., 2003; Katzelnick et al., 2011; Mulvahill et al., 2017; Raval et al., 2010; Rossom et al., 2016; Shittu et al., 2014; Wada et al., 2015; Waxmonsky et al., 2012), and (2) discussions with clinicians with expertise in treating patients with TRD. The potential predictors included demographic characteristics, treatment‐specific variables (e.g., site of care, nonpharmacologic treatment, number of prior MDD treatments, specific medications taken for MDD treatment), psychiatric comorbidities, medical comorbidities, measures of healthcare resource utilization, and others (see Table S2 for a full list of variables).…”
Section: Methodsmentioning
confidence: 99%
“…Depression further is associated with high morbidity and mortality, particularly due to impaired adherence to ART. 1,2 However, depression is under-recognized, under-diagnosed and undertreated, so screening for depression should be attempted regularly, especially at the time of diagnosis and before initiating HAART 3,4 Most western studies report the prevalence of depression in PLWHA as 2-3 times more than in the general population. Especially, studies after 1996, reported elevated rates of depression.…”
Section: Introductionmentioning
confidence: 99%